Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Schroeder Theodore R
Relationship:   Director
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   22,996    

Indirect Shares

   117,489      
Direct Value   $369,493    

Indirect Value

   $46,267      
Total Shares   140,485      
Total Value   $415,760      


Collegium Pharmaceutical, Inc $364,772 Nabriva Therapeutics AG $4,721 Collegium Pharmaceutical, Inc $364,772 Nabriva Therapeutics AG $4,721
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    1   
    0    
   
     Gain/Loss Ratio :
   -1.0   
   0.0   
     Percentage Gain/Loss :
   -100.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cadence Pharmaceuticals Inc CADX President, CEO, Director 2014-03-19 0 2014-03-19 0    Premium*  
            Hyperion Therapeutics Inc HPTX Director 2015-05-07 0 2014-08-13 0    Premium*  
            Collegium Pharmaceutical, Inc COLL Director 2020-05-20 11,007 2018-05-24 0    Premium*  
            Nabriva Therapeutics AG NBRV Director 2023-01-29 11,989 2019-08-27 117,489    Premium*  
* Premium Members only  

Records found :    90         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2020-12-31 4 D $2.42 $293 D/D (121) 64,518 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-01-31 4 D $2.62 $328 D/D (125) 181,893 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-01-31 4 D $0.48 $60 D/D (125) 314,611 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-02-28 4 D $0.45 $56 D/D (125) 314,223 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-04-06 4 D $0.41 $90 D/D (219) 313,637 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-03-06 4 D $1.79 $403 D/D (225) 178,760 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-04-06 4 D $1.73 $389 D/D (225) 178,535 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-05-06 4 D $1.49 $335 D/D (225) 178,203 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-06-06 4 D $1.34 $302 D/D (225) 177,871 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-07-06 4 D $1.27 $286 D/D (225) 177,539 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-08-06 4 D $1.17 $263 D/D (225) 177,207 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-09-06 4 D $1.11 $250 D/D (225) 176,875 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-10-06 4 D $1.08 $243 D/D (225) 226,543 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-11-06 4 D $1.33 $299 D/D (225) 226,211 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2021-12-06 4 D $0.72 $162 D/D (225) 225,879 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-05-06 4 D $0.26 $59 D/D (225) 313,305 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-06-06 4 D $0.20 $45 D/D (225) 312,973 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-07-06 4 D $0.18 $41 D/D (225) 312,641 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-08-06 4 D $0.18 $42 D/D (225) 312,309 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-09-06 4 D $0.16 $35 D/D (225) 311,977 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-02-06 4 D $0.48 $126 D/D (263) 314,348 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-03-06 4 D $0.43 $113 D/D (263) 313,960 0 -
NBRV Nabriva Therapeutics AG Chief Executive Officer   •       •      –    2022-01-06 4 D $0.58 $157 D/D (270) 325,502 0 -
NBRV Nabriva Therapeutics AG Director   –       •      –    2023-01-29 4 D $1.50 $647 D/D (431) 11,989 0 -
HPTX Hyperion Therapeutics Inc Director   –       •      –    2015-05-07 4 D $46.00 $28,382 D/D (617) 0 0 -
  90  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us